These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 10432739)
21. Adenovirus-mediated gene transfer of enhanced Herpes simplex virus thymidine kinase mutants improves prodrug-mediated tumor cell killing. Wiewrodt R; Amin K; Kiefer M; Jovanovic VP; Kapoor V; Force S; Chang M; Lanuti M; Black ME; Kaiser LR; Albelda SM Cancer Gene Ther; 2003 May; 10(5):353-64. PubMed ID: 12719705 [TBL] [Abstract][Full Text] [Related]
22. Coexpression of a multidrug resistance gene (MDR1) and herpes simplex virus thymidine kinase gene in a bicistronic retroviral vector Ha-MDR-IRES-TK allows selective killing of MDR1-transduced human tumors transplanted in nude mice. Sugimoto Y; Sato S; Tsukahara S; Suzuki M; Okochi E; Gottesman MM; Pastan I; Tsuruo T Cancer Gene Ther; 1997; 4(1):51-8. PubMed ID: 9012451 [TBL] [Abstract][Full Text] [Related]
23. The A167Y mutation converts the herpes simplex virus type 1 thymidine kinase into a guanosine analogue kinase. Balzarini J; Liekens S; Esnouf R; De Clercq E Biochemistry; 2002 May; 41(20):6517-24. PubMed ID: 12009916 [TBL] [Abstract][Full Text] [Related]
24. [Studies on thymidine kinase gene (TK) and GCV system for treatment of human retinoblastoma (RB)]. Liu J; Jing H; Zhang W; Liao S; Huang Q Hua Xi Yi Ke Da Xue Xue Bao; 2000 Sep; 31(3):300-3. PubMed ID: 12545814 [TBL] [Abstract][Full Text] [Related]
25. [Studies on herpes simplex virus thymidine kinase gene and GCV system for treatment of human bladder carcinoma]. He J; Chen Y; Li H; Lu Y; Yan Y; Tan X Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Jun; 21(3):428-32. PubMed ID: 15250149 [TBL] [Abstract][Full Text] [Related]
26. Purified herpes simplex virus thymidine kinase retroviral particles: III. Characterization of bystander killing mechanisms in transfected tumor cells. Burrows FJ; Gore M; Smiley WR; Kanemitsu MY; Jolly DJ; Read SB; Nicholas T; Kruse CA Cancer Gene Ther; 2002 Jan; 9(1):87-95. PubMed ID: 11916247 [TBL] [Abstract][Full Text] [Related]
31. Novel (E)-5-(2-iodovinyl)-2'-deoxyuridine derivatives as potential cytostatic agents against herpes simplex virus thymidine kinase gene transfected tumors. Balzarini J; Morin KW; Knaus EE; Wiebe LI; De Clercq E Gene Ther; 1995 Jul; 2(5):317-22. PubMed ID: 7671107 [TBL] [Abstract][Full Text] [Related]
32. Comparison of radiolabeled nucleoside probes (FIAU, FHBG, and FHPG) for PET imaging of HSV1-tk gene expression. Tjuvajev JG; Doubrovin M; Akhurst T; Cai S; Balatoni J; Alauddin MM; Finn R; Bornmann W; Thaler H; Conti PS; Blasberg RG J Nucl Med; 2002 Aug; 43(8):1072-83. PubMed ID: 12163634 [TBL] [Abstract][Full Text] [Related]
33. Mutation of Gln125 to Asn selectively abolishes the thymidylate kinase activity of herpes simplex virus type 1 thymidine kinase. Degrève B; Esnouf R; De Clercq E; Balzarini J Mol Pharmacol; 2001 Feb; 59(2):285-93. PubMed ID: 11160865 [TBL] [Abstract][Full Text] [Related]
34. Synthesis and in vitro evaluation of 5-[(18)f]fluoroalkyl pyrimidine nucleosides for molecular imaging of herpes simplex virus type 1 thymidine kinase reporter gene expression. Chacko AM; Qu W; Kung HF J Med Chem; 2008 Sep; 51(18):5690-701. PubMed ID: 18800764 [TBL] [Abstract][Full Text] [Related]
35. Experimental study of the RV-HSV-TK/GCV suicide gene therapy system in gastric cancer. Tang Q; Zhang D; Wan M; Jin L Cancer Biother Radiopharm; 2007 Dec; 22(6):755-61. PubMed ID: 18158766 [TBL] [Abstract][Full Text] [Related]
36. Molecular-genetic PET imaging using an HSV1-tk mutant reporter gene with enhanced specificity to acycloguanosine nucleoside analogs. Najjar AM; Nishii R; Maxwell DS; Volgin A; Mukhopadhyay U; Bornmann WG; Tong W; Alauddin M; Gelovani JG J Nucl Med; 2009 Mar; 50(3):409-16. PubMed ID: 19223410 [TBL] [Abstract][Full Text] [Related]
37. Functional coexpression of HSV-1 thymidine kinase and green fluorescent protein: implications for noninvasive imaging of transgene expression. Jacobs A; Dubrovin M; Hewett J; Sena-Esteves M; Tan CW; Slack M; Sadelain M; Breakefield XO; Tjuvajev JG Neoplasia; 1999 Jun; 1(2):154-61. PubMed ID: 10933050 [TBL] [Abstract][Full Text] [Related]
38. Comparison of HSV-1 thymidine kinase-dependent and -independent inhibition of replication-competent adenoviral vectors by a panel of drugs. Wildner O; Hoffmann D; Jogler C; Uberla K Cancer Gene Ther; 2003 Oct; 10(10):791-802. PubMed ID: 14502232 [TBL] [Abstract][Full Text] [Related]
39. A combined gene delivery by co-transduction of adenoviral and retroviral vectors for cancer gene therapy. Pan Y; Zhai P; Dashti AM; Wu S; Lin X; Wu M Cancer Lett; 2002 Oct; 184(2):179-88. PubMed ID: 12127690 [TBL] [Abstract][Full Text] [Related]
40. The bystander effect mediated by the new murine gammaherpesvirus 72--thymidine kinase/5'-fluoro-2'-deoxyuridine (MHV72-TK/5-FUdR) system in vitro. Raslova H; Matis J; Rezuchova I; Macakova K; Berebbi M; Kudelova M Antivir Chem Chemother; 2000 Jul; 11(4):273-82. PubMed ID: 10950389 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]